Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Ascendo Biotechnology Co., Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT06235437
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
🇨🇳Taipei Medical University Hospital, Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath